BONITAR 100 TABLET is an oral targeted therapy used for managing Philadelphia chromosome -positive chronic myeloid leukemia (Ph+ CML) in adult patients. It works by blocking specific proteins called tyrosine kinases, which are responsible for the uncontrolled growth of leukemia cells.
By inhibiting these proteins, bosutinib helps slow or stop the progression of cancer, improving long-term outcomes for patients who may not have responded well to other treatments.
This medication is usually taken once daily with food to enhance absorption and reduce the risk of stomach-related side effects. It is essential to follow the prescribed dosage carefully and attend regular medical check-ups to monitor blood counts, liver function, and overall response to therapy.
Grapefruit and grapefruit juice should be avoided, as they can increase the risk of side effects by affecting how bosutinib is processed in the body.
While BONITAR 100 TABLET is an effective therapy, it can cause side effects such as diarrhea, nausea, liver enzyme abnormalities, and low blood cell counts. Patients should inform their doctor about any existing health conditions, including liver, kidney, or heart problems, to ensure safe use.
Regular monitoring and supportive care can help manage potential side effects, improving the overall treatment experience. Always consult a doctor before starting or stopping bosutinib to ensure it is suitable for your condition.
No content available
